Treatment options of early-stage lung cancer: surgery or stereotactic body radiotherapy
10.3760/cma.j.issn.1004-4221.2019.09.016
- VernacularTitle: 早期非小细胞肺癌的治疗决择：手术或立体定向放疗
- Author:
Yanling WU
1
;
Qingfu FENG
;
Xiaodan WANG
;
Qiang ZENG
Author Information
1. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100021, China
- Publication Type:Review
- Keywords:
Lung neoplasms/stereotactic ablative radiotherapy;
Lung neoplasms/surgery;
Treatment outcome
- From:
Chinese Journal of Radiation Oncology
2019;28(9):709-712
- CountryChina
- Language:Chinese
-
Abstract:
For the treatment of early non-small cell lung cancer, surgery is still one of the most important curative treatments. Lung segment or subsegment resection under video-assisted thoracoscopic surgery is becoming more and more popular. With the development of radiotherapy technology, Stereotactic Body Radiotherapy (SBRT) has achieved the similar or the same curative effect as surgery. It has become an indisputable curative treatment for patients who can not or refuse surgery, and there are still some disputes among those who can operate. Therefore, this review will elaborate on these treatment methods in order to help update the concept and provide more treatment methods and obtain more benefits for patients. Although it is no randomized clinical trial to compare SBRT with surgery, we suggest that SBRT is the curative treatment for patients who can not or refuse surgery. Especially for the elderly, or patients with cardiopulmonary diseases, diabetes and other high-risks. SBRT should become the main treatment methods, because its curative effect is not inferior to surgery and its complications are fewer and lighter. Therefore, for the treatment of non-small cell lung cancer in the early stage, it is more importent to choose individualized treatment methods so as to more benefit.
